
Evolus rose 0.1% from $6.95 to $6.96, behind the S&P 500's +13.3%. Its worst day was Jan 14 (−12.2%), and its low came Mar 30 at $3.94.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Evolus shares fell 12.2%, while the S&P 500 fell 0.5%.
−12.2%, the year's worst day · S&P 500 −0.5%
EPS of $0.05 beat the $0.01 estimate on $90.3M revenue (est. $89.5M); FY revenue guidance of $327.0M–$337.0M against the $316.3M consensus.
Story events cover the past 12 months · Times ET
+35.4%, the year's best day, on 11M shares, the year's heaviest volume · S&P 500 +0.7%
Evolus closed at its lowest level of the year, 43.3% below where the year started.
−1.7% · S&P 500 −0.3%
EPS of $-0.16 missed the $-0.14 estimate on $73.1M revenue (est. $72.3M); FY revenue guidance of $327.0M–$337.0M against the $330.0M consensus.
+14.2% · S&P 500 +0.8%
EPS of $-0.12 missed the $-0.05 estimate on $84.1M revenue (est. $81.9M); FY revenue guidance of $330.0M–$337.0M against the $330.4M consensus.
+19.9% · S&P 500 −0.2%
Evolus closed at its highest level of the year, 33.8% above where the year started.
+2.8% · S&P 500 −0.4%
EPS of $-0.19 missed the $-0.08 estimate on $78.0M revenue (est. $77.5M); FY revenue guidance of $330.0M–$337.0M against the $334.1M consensus.
−9.0% · S&P 500 −4.4%
Where it ended: a close of $6.96 on Nov 13, 2026. Up next: Q4 2026 earnings on Mar 2, 2027 (EPS est. $0.04, revenue est. $99.2M).
Nothing in the past 12 months.
All EOLS dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EOLS and SPY from Benzinga historical bars. Not investment advice.